ClinicalTrials.gg

Program

encaleret

Its studies are mostly in Hypocalcemia · Hypoparathyroidism, led by BridgeBio.

Furthest: phase 3, since Dec 12, 20224 company-led studies, 3 open or runningNext primary completion: Jan 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
BridgeBio43 open or runningphase 3since Dec 12, 2022Sep 16, 2020Jan 2028phase 3 · NCT07805356

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 16, 2020First study: phase 2 study in Hypercalciuric Hypocalcemia, FamilialFirst studyNCT04581629 · 13 enrolled · United States
  2. Dec 12, 2022Phase 3 study in Hypercalciuric Hypocalcemia, FamilialNCT05680818 · 67 enrolled · United States, Australia, Canada and more
  3. Jul 14, 2025Phase 3 study in Autosomal Dominant Hypocalcemia Type 1 (ADH1)NCT07080385 · 28 planned · United States, United Kingdom
  4. Sep 1, 2026Phase 3 study in HypoparathyroidismNCT07805356 · 160 planned · United States, Canada, Japan

Ahead

  1. Jan 2028Primary completion: phase 3 study in HypoparathyroidismNCT07805356
  2. Dec 2028Primary completion: phase 3 study in Autosomal Dominant Hypocalcemia Type 1 (ADH1)NCT07080385

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07805356Hypoparathyroidism · United States, Canada, Japan3RecruitingJan 2028160
NCT07080385Autosomal Dominant Hypocalcemia Type 1 (ADH1) · United States, United Kingdom3RecruitingDec 202828
NCT05680818Hypercalciuric Hypocalcemia, Familial · United States, Australia, Canada and more3Active, not recruitingAug 22, 202567
NCT04581629Hypercalciuric Hypocalcemia, Familial · United States2CompletedSep 7, 202313

How it is read

Names in the registry

  • “Encaleret”, 4 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
encaleret (BridgeBio): development program | ClinicalTrials.gg